Hengrui Therapeutics, Inc. logo

Jiangsu Hengrui Medicine Co., Ltd..

Hengrui Therapeutics, Inc., a biopharmaceutical company, develops and commercializes drugs for oncology and endocrinology therapeutic areas.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”600276.SS” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.hengruitx.com
Founded2016
Disease Focus
Development Stage
STOCK CODESSE: 600276
Address
506 Carnegie Center, Suite 102, NJ 08540
Princeton
United States
Email
Contact Number
+1 609.423.2155

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/hengrui-therapeutics-inc.” connections=”true” suffix=””]